Peel Hunt reissued their buy rating on shares of Clinigen Group PLC (LON:CLIN) in a research note released on Tuesday morning. They currently have a GBX 1,350 ($17.81) target price on the stock.

Separately, Numis Securities Ltd downgraded shares of Clinigen Group PLC to an add rating and set a GBX 1,100 ($14.52) price target for the company. in a research report on Tuesday, July 18th. Two research analysts have rated the stock with a hold rating and three have given a buy rating to the company. Clinigen Group PLC presently has a consensus rating of Buy and an average target price of GBX 1,103 ($14.56).

Clinigen Group PLC (CLIN) opened at 1176.00 on Tuesday. The firm has a 50-day moving average of GBX 1,108.97 and a 200-day moving average of GBX 978.53. Clinigen Group PLC has a 52 week low of GBX 695.00 and a 52 week high of GBX 1,187.00. The company’s market cap is GBX 1.35 billion.

Clinigen Group PLC (LON:CLIN) last announced its quarterly earnings data on Thursday, September 28th. The company reported GBX 41.80 ($0.55) EPS for the quarter, topping the consensus estimate of GBX 41.20 ($0.54) by GBX 0.60 ($0.01). The company had revenue of £302.30 million during the quarter. Clinigen Group PLC had a net margin of 0.70% and a return on equity of 0.98%.

TRADEMARK VIOLATION WARNING: This story was first reported by TheOlympiaReport and is owned by of TheOlympiaReport. If you are accessing this story on another publication, it was illegally stolen and reposted in violation of US & international trademark & copyright laws. The legal version of this story can be viewed at https://theolympiareport.com/2017/11/01/clinigen-group-plc-clin-receives-buy-rating-from-peel-hunt.html.

The firm also recently declared a dividend, which will be paid on Friday, December 1st. Investors of record on Thursday, November 9th will be given a GBX 3.40 ($0.04) dividend. The ex-dividend date of this dividend is Thursday, November 9th. This represents a yield of 0.32%. This is an increase from Clinigen Group PLC’s previous dividend of $1.60.

In related news, insider John Bacon sold 250,000 shares of Clinigen Group PLC stock in a transaction on Monday, October 2nd. The shares were sold at an average price of GBX 1,093 ($14.42), for a total value of £2,732,500 ($3,605,832.67). Also, insider Shaun Edward Chilton sold 100,000 shares of Clinigen Group PLC stock in a transaction on Friday, October 13th. The shares were sold at an average price of GBX 1,150 ($15.18), for a total transaction of £1,150,000 ($1,517,550.80).

Clinigen Group PLC Company Profile

Analyst Recommendations for Clinigen Group PLC (LON:CLIN)

Receive News & Ratings for Clinigen Group PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clinigen Group PLC and related companies with Analyst Ratings Network's FREE daily email newsletter.